Literature DB >> 32093111

Insomnia in Schizophrenia Patients: Prevalence and Quality of Life.

David Batalla-Martín1, Angel Belzunegui-Eraso2, Eva Miralles Garijo1, Elena Martínez Martín1, Rosanna Romaní Garcia1, Jacobo San Miguel Heras1, Marina Lopez-Ruiz3, Maria Antonia Martorell-Poveda4.   

Abstract

Sleep disorders are often not regarded as an important health problem, despite their impact on heath. Insomnia is the most frequent sleep disorder in mental health. The aim is to quantify the prevalence of insomnia in a population with schizophrenic disorder and assess its influence on quality of life. This is a descriptive, analytical and cross-sectional study conducted in a sample of 267 schizophrenic patients over 18 years of age using consecutive non-probabilistic sampling. The variables of interest were collected by means of the "Cuestionario Oviedo de Sueño," "Insomnia Severity Index" and EuqoQol-5D. The estimation of insomnia in our schizophrenic population according to the International Classification of Disease (ICD-10) criteria was 23.2%. The likelihood of insomnia when there are problems in the quality of life is significant in all its dimensions: mobility OR: 3.54 (95% CI 1.88- 6.65), self-care OR: 2.69 (95% CI 1.36-5.32), usual activities OR: 3.56 (95% CI 1.97-6.44), pain/discomfort OR: 4.29 (95% CI 2.37-7.74) and anxiety/depression OR: 3.01 (95% CI 1.61-5.65). The prevalence of insomnia fluctuates depending on the diagnostic criteria; however, the schizophrenic population shows high prevalence in some clinical characteristics. People with insomnia have a lower quality of life.

Entities:  

Keywords:  Insomnia Severity Index; Oviedo Sleep Questionnaire; comorbidity; insomnia; mental health; prevalence; quality of life; schizophrenia; sleep disturbance

Year:  2020        PMID: 32093111     DOI: 10.3390/ijerph17041350

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  3 in total

Review 1.  Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder.

Authors:  Mera Alhusaini; Nermin Eissa; Ali K Saad; Rami Beiram; Bassem Sadek
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

2.  Quality of life in patients with schizophrenia: A 2-year cohort study in primary mental health care in rural China.

Authors:  Xiao-Yan He; Christine Migliorini; Zhuo-Hui Huang; Fei Wang; Rui Zhou; Zi-Lang Chen; Yao-Nan Xiao; Qian-Wen Wang; Shi-Bin Wang; Carol Harvey; Cai-Lan Hou
Journal:  Front Public Health       Date:  2022-09-07

3.  The Experience of Insomnia in Patients With Schizophrenic Disorder: A Qualitative Study.

Authors:  David Batalla-Martín; Maria-Antonia Martorell-Poveda; Angel Belzunegui-Eraso; Eva Miralles Garijo; Ana Del-Cuerpo Serratosa; JuanCarlos Valdearcos Pérez; Miquel Montané Escobar; Marina Lopez-Ruiz
Journal:  Front Psychiatry       Date:  2022-01-17       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.